Suggestions for How to Improve Oversight of Vaccine Medical Exemptions

A Viewpoint published today in JAMA Pediatrics discusses concerns about exploitable loopholes in state vaccination exemption policies. In it, Y. Tony Yang, ScD, LLM, MPH of the George Washington University’s Milken Institute School of Public Health and School of Nursing describes a recent high profile case in California. He and his coauthor, Ross D. Silverman, JD, MPH of the Indiana University Fairbanks School of Public Health outline more prevention-focused options for structuring and regulating medical and nonmedical vaccination exemption requests.

Ensuring the Stability and Continued Growth of Community Health Centers Should Be a Health Reform Priority, Sara Rosenbaum Argues

Professor Sara Rosenbaum In a commentary posted on Take Care, a major blog site that caters to the congressional and legal communities, Sara Rosenbaum explained why ensuring that nearly 1,400 community health centers don’t go “over the cliff” and lose 71 percent of their grant funding should be one of the health reform priorities in the upcoming Congress.

An Argument in Favor of Influenza Vaccine Mandates for Young Children

Young girl getting an immunization

In a Viewpoint published in JAMA Pediatrics, Y. Tony Yang, ScD, LLM, MPH makes a case for the value of influenza vaccine mandates for children between six months and five years of age, such as the one now in force in New York City (NYC) for children in city-regulated childcare and educational institutions.

Op-ed Protests Dismantling EPA’s Office of Children’s Health Protection

Milken Institute School of Public Health Dean Lynn R. Goldman is an author of the op-ed published in the New York Times.

State Policies Linked to Uptake of HPV Vaccine

State policies play a significant role in the usage of vaccinations to prevent human papilloma virus (HPV), the most common sexually transmitted infection in the U.S.  Wayne Psek, MD, PhD, of the George Washington University Milken Institute School of Public Health served as an author on a study that identified a combination of state policies that are associated with high uptake of the vaccine in children, which the U.S. Centers for Disease Control and Prevention recommends beginning when they are 11 or 12 years old.